Brixton Biosciences
Highly Engaged Employees
Highly Engaged EmployeesBusiness Services · Massachusetts, United States · 11-50 Employees
View Company Info for Free
Overview
Headquarters
1000 Massachusetts Ave Ste 101, Cambridg...Phone Number
(617) 500-0213Website
www.brixtonbio.comRevenue
<$5 MillionIndustry
ZI Rank: 1
Signal Type
Jan
Feb
Mar
Apr
May
Jun
ZI Rank
1
1
1
1
1
1
About Brixton Biosciences
Brixton Biosciences, a spin-out from Massachusetts General Brigham, is a clinical-stage life sciences company that develops novel therapies for treating pain. Its leadership team comprises experienced managers and key medical advisors, enabling a patient-centric strategy driven by the best of the best. Backed by deep research, the company addresses crucial unmet needs in the field of pain management, which has historically been dominated by systemic medicine. Brixton Biosciences' innovative therapeutics, such as its novel Neural Ice, have the potential to provide pain relief in a single and easy drug-free injectable that is a non-addictive, locally targeted, and comparatively long-lasting solution.Explore more
Popular SearchesBrixton Biosciences IncBrixton BiosciencesSIC Code 87,873NAICS Code 54,541Show moreBrixton Biosciences Org Chart
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is Brixton Biosciences your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Funding: Get notified immidiatlly once Brixton Biosciences has new funding data
Website visits: Recent activity has been detected on your website
Earning: See what the market has to say on Brixton Biosciences recently announced quarterly report
Check out if Brixton Biosciences is spiking on competitors!
Congratulate Masked Content for being promoted to Masked Content at Brixton Biosciences
Brixton Biosciences, which may be a good buyer, showed buying intent in Masked Content Topic
Product Launch: Get notified when Brixton Biosciences launches new products
Click to see if Brixton Biosciences had a recent Job posting/layoffs
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Check if Brixton Biosciences has recently received funding, and reach out quickly before it becomes old news!
Recommended Actions
Introduce yourself to Masked Content, who has shown a strong intent to purchase lately
Find 3 more new buyers
Compare Similar Companies to Brixton Biosciences
Compare insights from companies similar to Brixton Biosciences, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Company Profile Activity
Activity Insights
Brixton Biosciences is experiencing very low activity levels compared to other companies in the Business Services sector.
What does this means?
Brixton Biosciences is drawing exceptional interest within the Business Services industry, suggesting notable developments or strong market momentum, learn more about Brixton Biosciences.
Brixton Biosciences financials insights
Gather financial insights about Brixton Biosciences, including details on funding rounds, investors, total funding, and acquisitions, to gain a comprehensive understanding of their financial strategy.
2024
Series B
$33M
Grant
$2M
Brixton Biosciences Tech Stack
A closer look at the technologies used by Brixton Biosciences
See more technologies
Most Recent Scoops
Partnership
Project
Laboratory Operations, Medical Research, Clinical Operations
Funding
Project
Spending/Investment, Funding
Award
Award, Search, Medical Research, Business Finance, Clinical Operations, Finance, Operations
Funding
Funding
Funding
Funding
Brixton Biosciences News & Media
Brixton Biosciences Inks $33M in Series B Funding
CAMBRIDGE, MA, Brixton Biosciences, a clinical stage life sciences company, announced that it closed a Series B funding round of $33M.Brixton Biosciences Announces $33M in Series B Funding to Advance Novel Technology for the Treatment of Pain
After promising results from first-in-man studies with its novel Neural Ice™ technology, the Massachusetts-based company will use the capital to initiate pivotal clinical studies in both chronic and acute pain indications CAMBRIDGE, Mass., May 14, 2024 /PRNewswire/ -- Brixton Biosciences,...
Read more news
Top Business Services Companies
Top companies in Canada by revenue
Top companies in Australia by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding Brixton Biosciences
Sign Up For FreeTo access detailed company insights
Brixton Biosciences, a spin-out from Massachusetts General Brigham, is a clinical-stage life sciences company that develops novel therapies for treating pain. Its leadership team comprises experienced managers and key medical advisors, enabling a patient-centric strategy driven by the best of the best. Backed by deep research, the company addresses... Read More
